What are the NCCN guidelines on first-line treatment regimens for primary mediastinal B-cell lymphoma (PMBCL)?

Updated: Sep 14, 2019
  • Author: Sonali M Smith, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print


NCCN guidelines recommend the following first line treatment regimens (in order of preference) [20] :

  • DA-EPOCH-R: dose-adjusted etoposide, prednisone, vincristine cyclophosphamide, doxorubicin and rituximab (6 cycles); radiation therapy can be added for persistent focal disease
  • RCHOP + RT: rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (6 cycles) plus radiation therapy 
  • RCHOP + ICE with/without RT: rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (4 cycles) followed by ifosfamide, carboplatin, etoposide (3 cycles) with or without radiation therapy

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!